Muralidhar Bali
- SEC CIK
- 0001784138
No open-market purchases or sales filed in the past year.
Current role at each company
- SPRB Spruce Biosciences, Inc.Directoras of Jul 24, 2025
- OKUR OnKure Therapeutics, Inc.Directoras of Jun 8, 2023
- XCUR Exicure, Inc.Directoras of Jun 15, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Muralidhar Bali as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XCUR Exicure, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 (view filing)4:50 PM ET | May 19 | Same day | Muralidhar BaliDirector | PPurchase | +1.47M | $0.1937 | +$285.2K | +21.1%8.45M after |
OKUR OnKure Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 (view filing) | Jul 14 | 1 day | Muralidhar BaliDirector | PPurchase | +111.7K | $8.50 | +$949.8K | +5.7%2.07M after |